European Primary Care Cardiovascular Society

Hypertension

Adverse pregnancy outcomes reduced with treatment of chronic hypertension

3' education - Apr. 3, 2022 - Prof. Alan Tita, MD, PhD

An algorithm-based program for cardiovascular healthcare

3' education - Nov. 22, 2021 - Alexander J. Blood, MD

Use of non-physician providers to control BP: An ambitious project

3' education - Nov. 14, 2021 - Prof. Keith Ferdinand, MD

Consideration of BP lowering irrespective of prior CVD or baseline SBP

3' education - Sep. 30, 2020 - Kazem Rahimi, MD

Reduced blood pressure and incidence of hypertension with community-wide salt restriction

3' education - Sep. 16, 2019 - Paris, France - Prof. Jaime Miranda

Reduced CV risk with an intervention targeting identified barriers to care

3' education - Sep. 16, 2019 - Paris, France - Prof. J-D Schwalm
EPCCS Annual CV Summit

Recent updates to the international Hypertension Guidelines - where do they vary and what should we agree in primary care?

5' education - Mar. 21, 2019 - Lisbon, Portugal - Richard McManus & Richard Hobbs

ESC/ESH Guidelines on management of hypertension: what's new?

3' education - Feb. 11, 2019 - Prof. Bryan Williams - London, UK

EPCCS

3' education - Feb. 8, 2019

May Measurement Month: Get involved to increase awareness on elevated blood pressure

3' education - Feb. 6, 2019 - Prof. Neil Poulter - London, UK

The cardiovascular challenge for primary care in diabetes

10' education - July 10, 2018 - Prof. Richard Hobbs - Oxford, UK

Hypertension - Can we agree on diagnostic and therapeutic thresholds?

10' education - Mar. 16, 2018 - EPCCS 2018, Barcelona, Spain - Prof. Richard McManus, prof. Richard Hobbs and prof. Christos Lionis

Pharmacist intervention in American 'black barbershops' effective at lowering BP

3' education - Mar. 12, 2018 - ACC 2018, Orlando, FL, USA - Dr. Ronald Victor, MD - Los Angeles, CA, USA

Clinical outcomes and adverse effects comparable across various BP measurement methods in SPRINT

3' education - Nov. 20, 2017 - AHA 2017 - Anaheim, CA, USA - Dr. Sripal Bangalore - NYU Langone, New York, NY, USA.

Good BP measurement depends more on appropriate technique than on absence of staff

3' education - Nov. 25, 2017 - AHA 2017 - Anaheim, CA, USA - Prof Karen Johnson - Memphis, TN, VS
##SCROLLER_ITEMS_FULL_TITLE##

What can be learned from the latest hypertension trials?

10' education - May 26, 2017

Identifying and treating patients with true hypertension

10' education - Feb. 24, 2016 - Prague - EPCCS 2015

Alcohol as a risk factor for hypertension

3' education - Nov. 20, 2014 - Brussels, Belgium - Prof. Daniel Duprez (Minnesota, USA) - EPCCS 2014
##SCROLLER_ITEMS_FULL_TITLE##

Renal denervation for truly resistant hypertension

3' education - Feb. 18, 2014 - London - 5-6 September 2013
##SCROLLER_ITEMS_FULL_TITLE##

What's new in hypertension guidelines?

3' education - Oct. 18, 2013 - EPCCS, September 5-6, 2013 - Richard McManus
##SCROLLER_ITEMS_FULL_TITLE##

What is the best method for diagnosing hypertension?

3' education - Sep. 7, 2012 - EPCCS 2012 - prof Richard McManus

Safely lowering of LDL-c with bempedoic acid in subgroups of patients

News - Apr. 19, 2022

ACC 2022 Two analyses using data of four phase 3 trials show that treatment with bempedoic acid lowers LDL-c in patients with renal impairment and in patients with hypertension. In addition, the analyses showed that bempedoic acid was generally well tolerated in these patients.

Adverse pregnancy outcomes reduced with treatment of chronic hypertension

3' education - Apr. 3, 2022 - Prof. Alan Tita, MD, PhD
Prof. Tita shares the results of the CHAP trial, which showed that treatment of mild chronic hypertension in pregnant women to a BP goal <140/90 mmHg reduces adverse pregnancy outcomes and does not impair fetal growth.

ACC 2022 Prof. Tita shares the results of the CHAP trial, which showed that treatment of mild chronic hypertension in pregnant women to a BP goal <140/90 mmHg reduces adverse pregnancy outcomes and does not impair fetal growth.

An algorithm-based program for cardiovascular healthcare

3' education - Nov. 22, 2021 - Alexander J. Blood, MD
Alexander Blood talks about the design of a remote algorithm-based program for hypertension and lipid management and shares the outcomes of the first 10,000 patients enrolled in this program.

AHA 2021 Alexander Blood talks about the design of a remote algorithm-based program for hypertension and lipid management and shares the outcomes of the first 10,000 patients enrolled in this program.

Remote program for improvement of lipid and hypertension management

News - Nov. 22, 2021

AHA 2021 This remote hypertension and LDL-c management program enrolled over 10,000 patients at high CV risk. The program effectively improved hypertension and LDL-c control across a diverse health care network.

Use of non-physician providers to control BP: An ambitious project

3' education - Nov. 14, 2021 - Prof. Keith Ferdinand, MD
Prof. Ferdinand summarizes and discusses the results from the Chinese Rural Hypertension Control (CRHC) Project.

AHA 2021 Prof. Ferdinand summarizes and discusses the results from the Chinese Rural Hypertension Control (CRHC) Project.

BP control in rural China improved by village doctor-led intervention for hypertension treatment

News - Nov. 13, 2021

AHA 2021 In a cluster trial of villages, BP control was significantly improved by a village doctor-led intervention for hypertension treatment compared to usual care among hypertensive residents in rural China.

Characteristics, treatment and outcomes of contemporary AF patients in West-Europe

Literature - Oct. 26, 2021 - Erküner Ö, et al. - Neth Heart J 2021

This analysis of data from the EORP-AF LTG registry provides an overview of characteristics, treatment and 1-year outcomes of contemporary AF patients in the Netherlands and Belgium.

Quadruple combination pill to lower BP

News - Oct. 5, 2021

ESC 2021 The QUARTET trial showed that starting with a quarter-dose quadruple combination pill led to greater BP lowering compared to starting with standard dose monotherapy in patients with hypertension.

Stroke reduction with replacement of salt by a salt substitute

News - Sep. 12, 2021
The Salt Substitute and Stroke Study (SSaSS) showed that replacement of salt (100% NaCl) with a salt substitute (75% NaCl + 25% KCl) reduces the risk of stroke in people with prior stroke or hypertension.

ESC 2021 The Salt Substitute and Stroke Study (SSaSS) showed that replacement of salt (100% NaCl) with a salt substitute (75% NaCl + 25% KCl) reduces the risk of stroke in people with prior stroke or hypertension.

Women at early 40s with hypertension stage 1 have increased ACS risk during midlife

Literature - June 23, 2021 - Kringeland E, et al. - Eur J Prev Cardiol 2021
Women with hypertension stage 1 (130-139 mmHg) at their early 40s had an increased risk of ACS during midlife, while this association was non-significant in men after adjusting for CV risk factors.

Women with hypertension stage 1 (130-139 mmHg) at their early 40s had an increased risk of ACS during midlife, while this association was non-significant in men after adjusting for CV risk factors.

Systematic review on screening for hypertension

Literature - May 12, 2021 - Guirguis-Blake J, et al. - JAMA 2021

This systematic review for the US Preventive Services Task Force provides an overview of benefits and harms of screening for hypertension in adults and on the accuracy of screening and confirmatory BP measurements.

Scientifc Statement from the AHA on adverse pregnancy outcomes and CVD

Literature - Apr. 21, 2021 - Parikh NI et al. - Circulation. 2021

Adverse pregnancy outcomes (APOs) are associated with future development of CVD. The statement from the American Heart Association gives recommendations for strategies to reduce the long-term CVD risk in women with APOs.